Amphastar Pharmaceuticals (AMPH) Equity Income (2022 - 2024)
Amphastar Pharmaceuticals (AMPH) recorded quarterly Equity Income of -$573000.0 in Q1 2024, down 13.47% quarter-over-quarter from -$505000.0 in Q4 2023, and up 27.01% on a YoY basis from -$451158.5 in Q2 2023.
Amphastar Pharmaceuticals (AMPH) Equity Income (2022 - 2024) Analysis & Trends
Amphastar Pharmaceuticals' Equity Income history runs 3 years deep, the most recent figure standing at -$573000.0 for Q1 2024.
- In Q1 2024, Equity Income rose 27.01% year-over-year to -$573000.0; the TTM figure through Dec 2024 stood at -$573000.0 (up 71.08% YoY), while the FY2024 annual figure was -$573000.0, up 71.08% from the prior year.
- Equity Income was -$573000.0 for Q1 2024 at Amphastar Pharmaceuticals, down from -$505000.0 in the prior quarter.
- In the past five years, Equity Income ranged from a high of -$57000.0 in Q4 2022 to a low of -$785000.0 in Q1 2023.
- Historically, Equity Income has averaged -$414555.6 across 3 years, with a median of -$390000.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Equity Income slumped 785.96% in 2023, then climbed 27.01% in 2024.
- A 3-year view of Equity Income shows it stood at -$57000.0 in 2022, then plunged by 785.96% to -$505000.0 in 2023, then declined by 13.47% to -$573000.0 in 2024.
- The last three Equity Income figures came in at -$573000.0 (Q1 2024), -$505000.0 (Q4 2023), and -$390000.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -1.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 25.30 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 14.91 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -9.68 Mn |
| 10 | Amphastar Pharmaceuticals | 880.15 Mn | 880.15 Mn | 70.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -573,000.00 |
| Dec 31, 2023 | -505,000.00 |
| Sep 30, 2023 | -390,000.00 |
| Jun 30, 2023 | -301,000.00 |
| Mar 31, 2023 | -785,000.00 |
| Dec 31, 2022 | -57,000.00 |
| Sep 30, 2022 | -163,000.00 |
| Jun 30, 2022 | -254,000.00 |
| Mar 31, 2022 | -703,000.00 |